Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates

Transplantation

Volumn 96, Issue 4, 2013, Pages 394-399

  Franco Palacios, Carlos R ^a   Lieske, John C ^a   Wadei, Hani M ^b   Rule, Andrew D ^a   Fervenza, Fernando C ^a   Voskoboev, Nikolay ^a   Garovic, Vesna D ^a   Zand, Ladan ^a   Stegall, Mark D ^a   Cosio, Fernando G ^a   Amer, Hatem ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Diabetic nephropathy; Focal segmental glomerulosclerosis; IgA nephropathy; Membranous nephropathy; Polycystic kidney disease; Recurrent FSGS; Serum suPAR; Urine suPAR

Indexed keywords

BIOLOGICAL MARKER; CREATININE; SOLUBLE UROKINASE RECEPTOR; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ELISA KIT; FEMALE; FOCAL GLOMERULOSCLEROSIS; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A DEFICIENCY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEINURIA; RECURRENT DISEASE; RECURRENT FOCAL GLOMERULOSCLEROSIS; RISK ASSESSMENT; SOLUBLE UROKINASE RECEPTOR BLOOD LEVEL; SOLUBLE UROKINASE RECEPTOR URINE LEVEL; URINE LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RECURRENCE; SOLUBILITY;

EID: 84883457657     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182977ab1     Document Type: Article

References (17)

1. Scandling JD. Kidney transplant candidate evaluation. Semin Dial 2005; 18: 487.
2. Hickson LJ, Gera M, Amer H, et al. Kidney transplantation for primary focal segmental glomerulosclerosis: Outcomes and response to therapy for recurrence. Transplantation 2009; 87: 1232.
3. Swaminathan S, Leung N, Lager DJ, et al. Changing incidence of glomerular disease in Olmsted County, Minnesota: A 30-year renal biopsy study. Clin J Am Soc Nephrol 2006; 1: 483.
4. Swaminathan S, Lager DJ, Qian X, et al. Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. Nephrol Dial Transplant 2006; 21: 2607.
5. Audard V, Kamar N, Sahali D, et al. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation. Transpl Int 2012; 25: E62.
6. Araya CE, Dharnidharka VR. The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: A systematic review. J Transplant 2011; 2011: 374213.
7. Kattah AG, Fervenza FC, Roccatello D. Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases. Autoimmunity Rev 2013; 12: 854.
8. Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011; 17: 952.
9. Wei C, Trachtman H, Li J, et al. Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 2012; 23: 2051.
10. Reiser J,Wei C, Tumlin J. Soluble urokinase receptor and focal segmental glomerulosclerosis. Curr Opin Nephrol Hypertens 2012; 21: 428.
11. Yilmaz G, Koksal I, Karahan SC, et al. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome. Clin Biochem 2011; 44: 1227.
12. Wittenhagen P, Andersen JB, Hansen A, et al. Plasma soluble urokinase plasminogen activator receptor in children with urinary tract infection. Biomarker Insights 2011; 6: 79.
13. Thuno M, Macho B, Eugen-Olsen J. suPAR: The molecular crystal ball. Dis Markers 2009; 27: 157.
14. Sehestedt T, Lyngbaek S, Eugen-Olsen J, et al. Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events. Atherosclerosis 2011; 216: 237.
15. Pawlak K, Pawlak D, Mysliwiec M. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients. Thromb Res 2007; 120: 871.
16. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247.
17. Hervey GR. Determination of creatinine by the Jaffe reaction. Nature 1953; 171: 1125.